Ventilatory sensitivity to carbon dioxide before and after episodic hypoxia in women treated with testosterone

Journal of Applied Physiology

Volumn 102, Issue 5, 2007, Pages 1832-1838

  Ahuja, Deepti ^a   Mateika, Jason H ^a,b   Diamond, Michael P ^b   Badr, M Safwan ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Wayne State University   (United States)

Author keywords

Carbon dioxide rebreathing; Episodic hypoxia; Placebo; Ventilatory threshold

Indexed keywords

CARBON DIOXIDE; ESTRADIOL; ESTROGEN; PLACEBO; TESTOSTERONE;

ADULT; ARTICLE; BREATHING; CHEMORECEPTOR REFLEX; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HISTOGRAM; HUMAN; HYPEROXIA; HYPOXIA; LUNG VENTILATION; PATCH TEST; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SLEEP APNEA SYNDROME; TESTOSTERONE BLOOD LEVEL; TIDAL VOLUME; WAKEFULNESS;

ADMINISTRATION, CUTANEOUS; ADULT; ANOXIA; CARBON DIOXIDE; CHEMORECEPTORS; CROSS-OVER STUDIES; FEMALE; HUMANS; HYPEROXIA; PULMONARY VENTILATION; REFERENCE VALUES; REFLEX; RESPIRATORY CENTER; RESPIRATORY MECHANICS; SLEEP APNEA SYNDROMES; TESTOSTERONE; TIME FACTORS; WAKEFULNESS;

EID: 34247854796     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01178.2006     Document Type: Article

References (42)

1. Aitken ML, Franklin JL, Pierson DJ, Schoene RB. Influence of body size and gender on control of ventilation. J Appl Physiol 60: 1894-1899, 1986.
2. Badr MS, Toiber F, Skatrud JB, Dempsey J. Pharyngeal narrowing/occlusion during central sleep apnea. J Appl Physiol 78: 1806-1815, 1995.
3. Behan M, Thomas CF. Sex hormone receptors are expressed in identified respiratory motoneurons in male and female rats. Neuroscience 130: 725-734, 2005.
4. Behan M, Zabka AG, Thomas CF, Mitchell GS. Sex steroid hormones and the neural control of breathing. Respir Physiol Neurobiol 136: 249-263, 2003.
5. Berthon-Jones M, Sullivan CE. Ventilation and arousal responses to hypercapnia in normal sleeping humans. J Appl Physiol 57: 59-67, 1984.
6. Burger HG. Androgen production in women. Fertil Steril 77, Suppl 4: S3-S5, 2002.
7. Cala SJ, Sliwinski P, Cosio MG, Kimoff RJ. Effect of topical upper airway anesthesia on apnea duration through the night in obstructive sleep apnea. J Appl Physiol 81: 2618-2626, 1996.
8. Camargo CA. Obstructive sleep apnea and testosterone. N Engl J Med 309: 314-315, 1983.
9. Charbonneau M, Marin JM, Olha A, Kimoff RJ, Levy RD, Cosio MG. Changes in obstructive sleep apnea characteristics through the night. Chest 106: 1695-1701, 1994.
10. Dempsey JA. Crossing the apnoeic threshold: causes and consequences. Exp Physiol 90: 13-24, 2005.
11. Dexter DD, Dovre EJ. Obstructive sleep apnea due to endogenous testosterone production in a woman. Mayo Clin Proc 73: 246-248, 1998.
12. Duffin J. Role of acid-base balance in the chemoreflex control of breathing. J Appl Physiol 99: 2255-2265, 2005.
13. Duffin J, Mahamed S. Adaptation in the respiratory control system. Can J Physiol Pharmacol 81: 765-773, 2003.
14. Fanfulla F, Patruno V, Bruschi C, Rampulla C. Obstructive sleep apnoea syndrome: is the "half-night polysomnography" an adequate method for evaluating sleep profile and respiratory events? Eur Respir J 10: 1725-1729, 1997.
15. Fogel RB, Malhotra A, Pillar G, Pittman SD, Dunaif A, White DP. Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 86: 1175-1180, 2001.
16. Hiort O, Holterhus PM, Nitsche EM. Physiology and pathophysiology of androgen action. Baillieres Clin Endocrinol Metab 12: 115-132, 1998.
17. Jensen D, Wolfe LA, O'Donnell DE, Davies GA. Chemoreflex control of breathing during wakefulness in healthy men and women. J Appl Physiol 98: 822-828, 2005.
18. Khodadadeh B, Badr MS, Mateika JH. The ventilatory response to carbon dioxide and sustained hypoxia is enhanced after episodic hypoxia in OSA patients. Respir Physiol Neurobiol 150: 122-134, 2006.
19. Liu PY, Yee B, Wishart SM, Jimenez M, Jung DG, Grunstein RR, Handelsman DJ. The short-term effects of high-dose testosterone on sleep, breathing, and function in older men. J Clin Endocrinol Metab 88: 3605-3613, 2003.
20. Lowenstein EJ. Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome. Dermatol Ther 19: 210-223, 2006.
21. Mahamed S, Cunningham DA, Duffin J. Changes in respiratory control after three hours of isocapnic hypoxia in humans. J Physiol 547: 271-281, 2003.
22. Mahamed S, Duffin J. Repeated hypoxic exposures change respiratory chemoreflex control in humans. J Physiol 534: 595-603, 2001.
23. Mahamed S, Hanly PJ, Gabor J, Beecroft J, Duffin J. Overnight changes of chemoreflex control in obstructive sleep apnoea patients. Respir Physiol Neurobiol 146: 279-290, 2005.
24. Mateika JH, Mendello C, Obeid D, Badr MS. Peripheral chemoreflex responsiveness is increased at elevated levels of carbon dioxide after episodic hypoxia in awake humans. J Appl Physiol 96: 1197-1205, 2004.
25. Mateika JH, Omran Q, Rowley JA, Zhou XS, Diamond MP, Badr MS. Treatment with leuprolide acetate decreases the threshold of the ventilatory response to carbon dioxide in healthy males. J Physiol 561: 637-646, 2004.
26. Matsumoto AM, Sandblom R, Schoene R, Lee K, Giblin E, Pierson D, Bremner W. Testosterone replacement in hypogonadal men: effects of obstructive sleep apnea, respiratory drives, and sleep. Clin Endocrinol (Oxf) 22: 713-721, 1985.
27. Morelli C, Badr MS, Mateika JH. Ventilatory responses to carbon dioxide at low and high levels of oxygen are elevated after episodic hypoxia in men compared with women. J Appl Physiol 97: 1673-1680, 2004.
28. 2 inhalation in Caucasians. Respir Physiol 16: 337-350, 1972.
29. Prabhakar NR, Peng YJ, Yuan G, Kumar GK. Reactive oxygen species facilitate oxygen sensing. Novartis Found Symp 272: 95-99, 2006.
30. Sandblom RE, Matsumoto AM, Schoene RB, Lee KA, Giblin EC, Bremner WJ, Pierson DJ. Obstructive sleep apnea syndrome induced by testosterone administration. N Engl J Med 308: 508-510, 1983.
31. Schlenker EH, Goldman M, Holman G. Control of ventilation in androgenized hypogonadal male rats. Physiol Behav 51: 581-584, 1992.
32. Schlenker EH, Hansen SN. Sex-specific densities of estrogen receptors alpha and beta in the subnuclei of the nucleus tractus solitarius, hypoglossal nucleus and dorsal vagal motor nucleus weanling rats. Brain Res 1123: 89-100, 2006.
33. Schneider BK, Pickett CK, Zwillich CW, Weil JV, McDermott MT, Santen RJ, Varano LA, White DP. Influence of testosterone on breathing during sleep. J Appl Physiol 61: 618-623, 1986.
34. 2 chemoreflex drive of ventilation in man: effects of hyperoxia and sex differences. Respiration 57: 264-267, 1990.
35. Sforza E, Krieger J, Petiau C. Nocturnal evolution of respiratory effort in obstructive sleep apnoea syndrome: influence on arousal threshold. Eur Respir J 12: 1257-1263, 1998.
36. Shahar E, Redline S, Young T, Boland LL, Baldwin CM, Nieto FJ, O'Connor GT, Rapoport DM, Robbins JA. Hormone replacement therapy and sleep-disordered breathing. Am J Respir Crit Care Med 167: 1186-1192, 2003.
37. Shea SA. Behavioural and arousal-related influences on breathing in humans. Exp Physiol 81: 1-26, 1996.
38. van Klaveren RJ, Demedts M. Determinants of the hypercapnic and hypoxic response in normal man. Respir Physiol 113: 157-165, 1998.
39. Vgontzas AN, Legro RS, Bixler EO, Grayev A, Kales A, Chrousos GP. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab 86: 517-520, 2001.
40. White DP, Douglas NJ, Pickett CK, Weil JV, Zwillich CW. Sexual influence on the control of breathing. J Appl Physiol 54: 874-879, 1983.
41. Young T, Finn L, Austin D, Peterson A. Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med 167: 1181-1185, 2003.
42. Zhou XS, Rowley JA, Demirovic F, Diamond MP, Badr MS. Effect of testosterone on the apneic threshold in women during NREM sleep. J Appl Physiol 94: 101-107, 2003.